Fifth Third Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fifth Third Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,471	Closed	-$206K	–	219
2023 Q2	$206K	Sell	2,471 -219	-8%	-$18.3K	0.02%	209
2023 Q1	$205K	Sell	2,690 -250	-9%	-$20.7K	0.02%	209
2022 Q4	$244K	Buy	2,940 +182	+7%	+$14.7K	0.03%	195
2022 Q3	$219K	Buy	+2,758	New	+$233K	0.03%	192
2021 Q2	–	Sell	-16,799	Closed	-$2.28M	–	84
2021 Q1	$2.28M	Sell	16,799 -3,698	-18%	-$554K	0.94%	28
2020 Q4	$2.89M	Sell	20,497 -3,470	-14%	-$444K	1.36%	24
2020 Q3	$2.67M	Buy	+23,967	New	+$2.69M	1.43%	22

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fifth Third Securities's XBI Position: Q3 2023 in Review

Fifth Third Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 2,471 shares — an estimated $206K sold.

Fifth Third Securities first reported a position in XBI in Q3 2020 and held it in 7 quarters. The position peaked at $2.89M in Q4 2020. 677 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Fifth Third Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Fifth Third Securities sold 2,471 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $206K.
Fifth Third Securities first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and held it in 7 quarters.
Fifth Third Securities's State Street SPDR S&P Biotech ETF position peaked at $2.89M in Q4 2020.
677 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Fifth Third Securities's 13F filing for Q3 2023, filed 12 Oct 2023.